Novel paradigm attenuates traumatic memories and prevents return of fear

新颖的范例可以减轻创伤记忆并防止恐惧再次出现

基本信息

  • 批准号:
    8011230
  • 负责人:
  • 金额:
    $ 17.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-01 至 2012-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exaggerated or persistent fear is a common occurrence in psychiatric disorders. Although much progress has been made in uncovering the neural basis of fear learning through studies of Pavlovian conditioning, little is known about how to reduce or eliminate traumatic memories in pathological cases, which is of great clinical concern. Associative emotional memories can be formed when an initially neutral stimulus (conditioned stimulus, CS; e.g., a tone) acquires the ability to elicit fear responses after being paired with an unconditioned stimulus (US; e.g., a shock). Two paradigms (blockade of reconsolidation and extinction) have been used in the laboratory setting to reduce acquired fear (Nader et al., 2000; REF, YEAR); however, the clinical efficacy of these techniques has been limited: reconsolidation blockade requires potentially toxic drugs, while extinction is not typically permanent. My preliminary findings indicated that we have devised a novel behavioral paradigm that attenuates and prevents the return of fear memories. Our results indicate that subtle modifications to a commonly employed clinical treatment (exposure therapy) could greatly improve outcome, and reduce the potential for relapse in individuals suffering from post-traumatic stress disorder or specific phobias. In the proposed studies, I propose to examine the neural mechanisms that underlie this persistent attenuation of fear, in order to disambiguate how our novel paradigm distinguishes itself from standard extinction mechanisms. We will perform these experiments in rat and human studies in parallel, and then test whether this form of therapy can be used to treat individuals that suffer from specific phobias. PUBLIC HEALTH RELEVANCE: Exaggerated or persistent fear is a common occurrence in psychiatric disorders. Two paradigms (blockade of reconsolidation and extinction) have been used in the laboratory setting to reduce acquired fear; however, the clinical efficacy of these techniques has been limited. Here, we present a novel behavioral paradigm that attenuates and prevents the return of fear memories. Our findings indicate that subtle modifications to a commonly employed clinical treatment (exposure therapy) could greatly improve outcome, and reduce the potential for relapse in individuals suffering from post-traumatic stress disorder or specific phobias.
描述(由申请人提供):夸大或持续的恐惧是精神疾病中常见的现象。虽然通过巴甫洛夫条件反射的研究在揭示恐惧学习的神经基础方面取得了很大进展,但对于如何减少或消除病理情况下的创伤记忆知之甚少,这是一个非常重要的临床问题。当最初的中性刺激(条件刺激,CS;例如,音调)在与无条件刺激(US;例如,震惊)。在实验室环境中已经使用了两种范例(阻断再巩固和消退)来减少获得性恐惧(Nader等人,二○年; REF,YEAR);然而,这些技术的临床效果有限:再巩固阻断需要潜在的毒性药物,而消退通常不是永久性的。我的初步研究结果表明,我们已经设计出一种新的行为模式,可以减弱和阻止恐惧记忆的回归。我们的研究结果表明,对常用的临床治疗(暴露疗法)进行细微的修改可以大大改善结果,并降低患有创伤后应激障碍或特定恐惧症的个体复发的可能性。在拟议的研究中,我建议检查这种持续衰减恐惧的神经机制,以消除歧义,我们的新范式如何区分自己从标准的灭绝机制。我们将在大鼠和人类研究中平行进行这些实验,然后测试这种形式的疗法是否可以用于治疗患有特定恐惧症的个体。 公共卫生相关性:夸大或持续的恐惧在精神疾病中很常见。两种范例(阻断再巩固和消退)已被用于在实验室设置,以减少获得性恐惧,然而,这些技术的临床疗效有限。在这里,我们提出了一种新的行为模式,衰减和防止恐惧记忆的回归。我们的研究结果表明,对常用的临床治疗(暴露疗法)进行细微的修改可以大大改善结果,并降低患有创伤后应激障碍或特定恐惧症的个体复发的可能性。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Learned together, extinguished apart: reducing fear to complex stimuli.
Post-retrieval extinction as reconsolidation interference: methodological issues or boundary conditions?
  • DOI:
    10.1007/s00213-013-3004-1
  • 发表时间:
    2013-04
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Auber, Alessia;Tedesco, Vincenzo;Jones, Carolyn E.;Monfils, Marie-H.;Chiamulera, Christian
  • 通讯作者:
    Chiamulera, Christian
Fear conditioning by-proxy: social transmission of fear during memory retrieval.
  • DOI:
    10.1016/j.bbr.2010.04.047
  • 发表时间:
    2010-12-06
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Bruchey, Aleksandra K.;Jones, Carolyn E.;Monfils, Marie-H.
  • 通讯作者:
    Monfils, Marie-H.
Updating appetitive memory during reconsolidation window: critical role of cue-directed behavior and amygdala central nucleus.
  • DOI:
    10.3389/fnbeh.2013.00186
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Olshavsky ME;Song BJ;Powell DJ;Jones CE;Monfils MH;Lee HJ
  • 通讯作者:
    Lee HJ
Extinction and Retrieval + Extinction of Conditioned Fear Differentially Activate Medial Prefrontal Cortex and Amygdala in Rats.
  • DOI:
    10.3389/fnbeh.2015.00369
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Lee HJ;Haberman RP;Roquet RF;Monfils MH
  • 通讯作者:
    Monfils MH
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marie H. Monfils其他文献

Post-retrieval extinction can attenuate recovery and reinstatement of conditioned reactivity to alcohol cues in Long-Evans rats
  • DOI:
    10.1016/j.alcohol.2017.02.296
  • 发表时间:
    2017-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Roberto U. Cofresí;Nadia Chaudhri;Hongjoo J. Lee;Marie H. Monfils;Rueben A. Gonzales
  • 通讯作者:
    Rueben A. Gonzales

Marie H. Monfils的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marie H. Monfils', 18)}}的其他基金

1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy
1/2:二氧化碳反应性作为暴露治疗无反应的生物标志物
  • 批准号:
    10614375
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
1/2: CO2 Reactivity as a Biomarker of Non-response to Exposure-based Therapy
1/2:二氧化碳反应性作为暴露治疗无反应的生物标志物
  • 批准号:
    10363873
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
Fear memory attenuation: testing reconsolidation-extinction boundaries
恐惧记忆衰减:测试再巩固-消退边界
  • 批准号:
    8042481
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:
Novel paradigm attenuates traumatic memories and prevents return of fear
新颖的范例可以减轻创伤记忆并防止恐惧再次出现
  • 批准号:
    7789363
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:
Fear memory attenuation: testing reconsolidation-extinction boundaries
恐惧记忆衰减:测试再巩固-消退边界
  • 批准号:
    8389682
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:
Fear memory attenuation: testing reconsolidation-extinction boundaries
恐惧记忆衰减:测试再巩固-消退边界
  • 批准号:
    8204555
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:
Fear memory attenuation: testing reconsolidation-extinction boundaries
恐惧记忆衰减:测试再巩固-消退边界
  • 批准号:
    8777019
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:
Fear memory attenuation: testing reconsolidation-extinction boundaries
恐惧记忆衰减:测试再巩固-消退边界
  • 批准号:
    8585103
  • 财政年份:
    2010
  • 资助金额:
    $ 17.89万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 17.89万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 17.89万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了